Editorial: Building capacity for sickle cell disease research and healthcare.
作者信息
Nembaware Victoria, Nnodu Obiageli Eunice, Sangeda Raphael Zozimus, Paintsil Vivian, Mazandu Gaston Kuzamunu, Munung Nchangwi S, Wonkam Ambroise, Martí-Carvajal Arturo J
机构信息
Division of Human Genetics, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Centre of Excellence for Sickle Cell Disease Research and Training (CESRTA), University of Abuja, Abuja, Nigeria.
出版信息
Front Genet. 2023 Jul 12;14:1226589. doi: 10.3389/fgene.2023.1226589. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Building capacity for sickle cell disease research and healthcare.社论：加强镰状细胞病研究与医疗保健能力建设。
Front Genet. 2023 Jul 12;14:1226589. doi: 10.3389/fgene.2023.1226589. eCollection 2023.
2
Establishing a Sickle Cell Disease Registry in Africa: Experience From the Sickle Pan-African Research Consortium, Kumasi-Ghana.在非洲建立镰状细胞病登记处：来自加纳库马西镰状细胞病泛非研究联盟的经验
Front Genet. 2022 Feb 24;13:802355. doi: 10.3389/fgene.2022.802355. eCollection 2022.
3
Establishing a Multi-Country Sickle Cell Disease Registry in Africa: Ethical Considerations.在非洲建立多国镰状细胞病登记处：伦理考量
Front Genet. 2019 Oct 10;10:943. doi: 10.3389/fgene.2019.00943. eCollection 2019.
4
Skills Capacity Building For Health Care Services and Research Through the Sickle Pan African Research Consortium.通过镰状细胞病泛非研究联盟开展医疗服务与研究的技能能力建设
Front Genet. 2022 Jun 15;13:805806. doi: 10.3389/fgene.2022.805806. eCollection 2022.
5
Strengthening Health System and Community Mobilization for Sickle Cell Disease Screening and Management among Tribal Populations in India: An Interventional Study.强化卫生系统和社区动员，在印度部落人群中开展镰状细胞病筛查和管理：一项干预研究。
Hemoglobin. 2023 Nov;47(6):227-236. doi: 10.1080/03630269.2023.2300675. Epub 2024 Jan 22.
6
The Sickle Cell Disease Ontology: Enabling Collaborative Research and Co-Designing of New Planetary Health Applications.镰状细胞病本体论：支持协作研究和新行星健康应用的共同设计。
OMICS. 2020 Oct;24(10):559-567. doi: 10.1089/omi.2020.0153.
7
Development of multi-level standards of care recommendations for sickle cell disease: Experience from SickleInAfrica.镰状细胞病多级护理建议标准的制定：来自非洲镰状细胞病项目的经验
Front Genet. 2023 Jan 12;13:1052179. doi: 10.3389/fgene.2022.1052179. eCollection 2022.
8
Bridging the Access Gap for Comprehensive Sickle Cell Disease Management Across Sub-Saharan Africa: Learnings for Other Global Health Interventions?弥合撒哈拉以南非洲地区全面镰状细胞病管理中的获取障碍：对其他全球卫生干预措施的启示？
Ann Glob Health. 2023 Nov 14;89(1):76. doi: 10.5334/aogh.4132. eCollection 2023.
9
Strategies to improve healthcare services for patients with sickle cell disease in Nigeria: The perspectives of stakeholders.尼日利亚改善镰状细胞病患者医疗服务的策略：利益相关者的观点。
Front Genet. 2023 Feb 3;14:1052444. doi: 10.3389/fgene.2023.1052444. eCollection 2023.
10
Developing a global agenda for sickle cell disease: report of an international symposium and workshop in Cotonou, Republic of Benin.制定全球镰状细胞病议程：贝宁共和国科托努国际研讨会和讲习班报告。
Am J Prev Med. 2010 Apr;38(4 Suppl):S571-5. doi: 10.1016/j.amepre.2009.12.021.
本文引用的文献
1
The future of sickle cell disease therapeutics rests in genomics.镰状细胞病治疗的未来在于基因组学。
Dis Model Mech. 2023 Feb 1;16(2). doi: 10.1242/dmm.049765. Epub 2023 Feb 23.
2
Caring for Africa's sickle cell children: will we rise to the challenge?关爱非洲镰状细胞病患儿：我们能迎接挑战吗？
BMC Med. 2020 Apr 28;18(1):92. doi: 10.1186/s12916-020-01557-2.
3
SickleInAfrica.非洲的镰状细胞（病） （注：原文信息不完整，推测可能是指与镰状细胞相关的某种情况，比如镰状细胞贫血等在非洲的情况 ）
Lancet Haematol. 2020 Feb;7(2):e98-e99. doi: 10.1016/S2352-3026(20)30006-5.
4
Sickle cell disease in sub-Saharan Africa: stakes and strategies for control of the disease.撒哈拉以南非洲的镰状细胞病：控制该疾病的利害关系和策略。
Curr Opin Hematol. 2014 May;21(3):210-4. doi: 10.1097/MOH.0000000000000038.
5
Sickle cell disease in Africa: a neglected cause of early childhood mortality.非洲的镰状细胞病：被忽视的儿童早期死亡原因。
Am J Prev Med. 2011 Dec;41(6 Suppl 4):S398-405. doi: 10.1016/j.amepre.2011.09.013.
6
Sickle-cell disease.镰状细胞病。
Lancet. 2010 Dec 11;376(9757):2018-31. doi: 10.1016/S0140-6736(10)61029-X. Epub 2010 Dec 3.
Zotero 插件